Amyris Announces Multi-Year Technology Investment Agreement With DARPA Worth Up to $35 Million
(Amyris) Anticipated to Expand Portfolio by Adding Hundreds of Molecules Across Multiple Development Platforms - Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced a multi-year, Technology Investment Agreement (TIA) worth up to $35 million with the Defense Advanced Research Projects